GUIDE
to
xyntha
CLOSE

GUIDE TO
XYNTHA

Guide

Download Arrow

Download
GUIDE TO XYNTHA
as PDF

CONTACT
DETAILS

HAEMOPHILIA TREATMENT CENTRES.

Auckland

Haematology Department

Auckland City Hospital

2 Park Road, Grafton

Private Bag 92024 Victoria St. West

Auckland 1142

Ph: 09 307 2829

Waikato

Haematology Department

Waikato Hospital

Pembroke Street,
Hamilton

Private Bag 3200

Waikato Mail Centre 3420

Ph: 07 839 8899

Christchurch

Haematology Department

Christchurch Hospital

Riccarton Ave

Private Bag 4710

Christchurch 8140

Ph: 03 364 1246

Palmerston North

Haematology Department

Palmerston North Hospital

50 Ruahine Street

Private Bag 11036

Palmerston North 4442

Ph: 06 350 8770

Wellington

Blood and Cancer Centre

Wellington Hospital

Riddiford Street, Newtown

Private Bag 7902

Wellington South 6242

04 806 2101

Dunedin

Haematology Department

Dunedin Hospital

201 Great King St, Dunedin

Private Bag 1921

Dunedin 9054

Ph: 03 474 0999

It’s well worth joining the Haemophilia Foundation of New Zealand for further support, and to stay up to date with any new developments in the treatment of haemophilia. You can contact the foundation at www.haemophilia.org.nz or phone the National Office on 0508 factor (322867).

XYNTHA (moroctocog alfa (rch) (recombinant coagulation factor VIII))
250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU

XYNTHA (moroctocog alfa (rch)) is a funded medicine that is prescribed by a doctor for the control and treatment of bleeding and the routine and surgical prevention of bleeding in patients with haemophilia A. A pharmacy charge and normal doctor’s fees apply. Xyntha has risks and benefits. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your doctor if you have had an allergic reaction to hamster protein or any of the other ingredients of XYNTHA. XYNTHA must be used with caution in certain people, including: people with factor VIII inhibitors, people with allergies, people changing from other factor VIII medicines to XYNTHA, and pregnant or breastfeeding women. Ask your doctor for advice. Uncommon to very rare serious side effects include numbness, chest pain, rapid or irregular heartbeat, shortness of breath, bleeding and low blood pressure. If you have side effects see your doctor. If you suddenly experience a swollen face, lips, tongue or throat, shortness of breath, chest tightness, wheezing, dizziness, faintness, chills, flushing, tiredness, restlessness, nausea, vomiting, rapid heartbeat, headache, tingling, burning and stinging at the injection site, hives or skin rash, STOP taking XYNTHA and seek urgent medical attention. These may be signs of a serious allergic reaction. Tell your doctor immediately if you are using increasing amounts of XYNTHA in order to control a bleeding episode. Use strictly as directed. Consult your doctor to see if XYNTHA is right for you. Contains moroctocog alfa (rch) 250, 500, 1000, 2000, 3000 IU/vial or syringe.

Further information on XYNTHA is available from www.medsafe.govt.nz or Pfizer New Zealand Limited, Auckland, www.pfizer.co.nz. Ph. 0800 736 363. V11216 Pfizer New Zealand, Level 1, Suite 1.4, Building B, 8 Nugent Street, Grafton, Auckland 1023. PPZR0332 PP-XYN-NZL-0063, NA 9403 09/17.

XYNTHA® is a registered trademark.
© Pfizer 2017

www.medsafe.govt.nz

www.haemophilia.org.nz

© 2017 Pfizer New Zealand Limited, Auckland. All rights reserved.

Privacy Policy  |  Legal Policy